PLS models discriminate types of MS from spectroscopic analysis of plasma and urinele

PLS models discriminate types of MS from spectroscopic analysis of plasma and urinele

Bibliografiset tiedot
Päätekijät:	Dickens, A, Anthony, D, Claridge, T, Mardiguian, S, Cavay, A, Davis, B, Griffin, J, Campbell, S, Palace, J, Sibson, N
Aineistotyyppi:	Conference item
Julkaistu:	2009

Samankaltaisia teoksia

NMR-Based Metabolomics Separates the Distinct Stages of Disease in a Chronic Relapsing Model of Multiple Sclerosis.
Tekijä: Dickens, A, et al.
Julkaistu: (2015)

NMR-Based Metabolomics Separates the Distinct Stages of Disease in a Chronic Relapsing Model of Multiple Sclerosis
Tekijä: Dickens, A, et al.
Julkaistu: (2015)

A type 2 biomarker separates relapsing-remitting from secondary progressive multiple sclerosis.
Tekijä: Dickens, A, et al.
Julkaistu: (2014)

Early diagnosis of brain tumours through biofluid metabolomics
Tekijä: Larkin, J, et al.
Julkaistu: (2016)

Early diagnosis of brain metastases through biofluid metabolomics
Tekijä: Larkin, JR, et al.
Julkaistu: (2017)

OPLS discriminant analysis: combining the strengths of PLS-DA and SIMCA classification
Tekijä: Bylesjo, M, et al.
Julkaistu: (2006)

Early diagnosis of brain metastases using a biofluids-metabolomics approach in mice
Tekijä: Larkin, J, et al.
Julkaistu: (2016)

Implementation of PLS discriminant analysis to rank indirubin derivatives against decoys
Tekijä: Crisan Luminita, et al.
Julkaistu: (2013-10-01)

Spectroscopic Discrimination of Sorghum Silica Phytoliths
Tekijä: Victor M. R. Zancajo, et al.
Julkaistu: (2019-12-01)

The hepatic response in multiple sclerosis
Tekijä: Mardiguian, S, et al.
Julkaistu: (2008)

VCAM-1-targeted magnetic resonance imaging reveals subclinical disease in a mouse model of multiple sclerosis.
Tekijä: Serres, S, et al.
Julkaistu: (2011)

Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease.
Tekijä: Jurynczyk, M, et al.
Julkaistu: (2017)

Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease
Tekijä: Jurynczyk, M, et al.
Julkaistu: (2017)

Partnership and consent in MS treatment choice.
Tekijä: Palace, J
Julkaistu: (2013)

Partnership and consent in MS treatment choice
Tekijä: Palace, J
Julkaistu: (2013)

Sparse PLS discriminant analysis: biologically relevant feature selection and graphical displays for multiclass problems
Tekijä: Besse Philippe, et al.
Julkaistu: (2011-06-01)

Pre-symptomatic detection of experimental autoimmune encephalomyelitis using in vivo magnetic resonance imaging of VCAM-1
Tekijä: Mardiguian, S, et al.
Julkaistu: (2009)

Determination of CSF GFAP, CCN5, and vWF levels enhances the diagnostic accuracy of clinically defined MS from non-MS patients with CSF oligoclonal bands
Tekijä: Probert, F, et al.
Julkaistu: (2022)

Indirect Nuclear Magnetic Resonance (NMR) Spectroscopic Determination of Acrylamide in Coffee Using Partial Least Squares (PLS) Regression
Tekijä: Vera Rief, et al.
Julkaistu: (2021-05-01)

Clinical and laboratory characteristics of secondary progressive MS.
Tekijä: Palace, J
Julkaistu: (2003)

Laser spectroscopic studies of plasma
Tekijä: Rogers, SDA
Julkaistu: (2022)

Optimal Weighted Learning of PCA and PLS for Multicollinearity Discriminators and Imbalanced Groups in Big Data (S/O: 13224)
Tekijä: Mahat, Nor Idayu, et al.

A spectroscopic test suggests that fragment ion structure annotations in MS/MS libraries are frequently incorrect
Tekijä: Lara van Tetering, et al.
Julkaistu: (2024-02-01)

Evaluation of Multivariate Filters on Vibrational Spectroscopic Fingerprints for the PLS-DA and SIMCA Classification of Argan Oils from Four Moroccan Regions
Tekijä: Meryeme El Maouardi, et al.
Julkaistu: (2023-07-01)

Conformational effects in sugar ions: spectroscopic investigations in the gas phase and in solution
Tekijä: Sagar, R, et al.
Julkaistu: (2012)

Speech discrimination in the elderly
Tekijä: L. P. Dickens
Julkaistu: (1987-12-01)

Plasma nuclear magnetic resonance metabolomics discriminates between high and low endoscopic activity and predicts progression in a prospective cohort of patients with ulcerative colitis
Tekijä: Probert, F, et al.
Julkaistu: (2018)

Spectroscopic and chromatographic technique for forensic discrimination of marker pen inks /
Tekijä: Ayathull Dhalayla Mohd. Jar, 1986-, et al.
Julkaistu: (2009)

Spectroscopic Discrimination of Bee Pollen by Composition, Color, and Botanical Origin
Tekijä: Roman Bleha, et al.
Julkaistu: (2021-07-01)

ANTI-IL17 TREATMENT REDUCES CLINICAL SCORE AND VCAM-1 EXPRESSION IN EAE-ABH MICE DETECTED BY IN VIVO MAGNETIC RESONANCE IMAGING
Tekijä: Serres, S, et al.
Julkaistu: (2009)

PLS2 in Metabolomics
Tekijä: Matteo Stocchero, et al.
Julkaistu: (2019-03-01)

SPECTROSCOPIC DIAGNOSIS IN ELECTRONIC TEMPERATURE OF PHOTOIONISE PLASMAS
Tekijä: A. K. Ferouani, et al.
Julkaistu: (2015-08-01)

The UK MS database
Tekijä: Palace, J, et al.
Julkaistu: (2002)

Plasma exchange for MS.
Tekijä: Noseworthy, J, et al.
Julkaistu: (1990)

PLASMA-EXCHANGE FOR MS
Tekijä: Noseworthy, J, et al.
Julkaistu: (1990)

First spectroscopic studies in the plasma-beam installation
Tekijä: B. Chektybayev, et al.
Julkaistu: (2024-09-01)

The complexity of gradient descent: CLS = PPAD ∩ PLS
Tekijä: Fearnley, J, et al.
Julkaistu: (2021)

The complexity of gradient descent: CLS = PPAD∩PLS
Tekijä: Fearnley, J, et al.
Julkaistu: (2022)

The measurement of antibodies binding to IFNbeta in MS patients treated with IFNbeta.
Tekijä: Pachner, A, et al.
Julkaistu: (2003)

The measurement of antibodies binding to IFNbeta in MS patients treated with IFNbeta.
Tekijä: Pachner, A, et al.
Julkaistu: (2003)